<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03526991</url>
  </required_header>
  <id_info>
    <org_study_id>AAAR7729</org_study_id>
    <nct_id>NCT03526991</nct_id>
  </id_info>
  <brief_title>Spinal Cord Stimulation (SCS) for Freezing of Gait (FOG) in Parkinson's Disease</brief_title>
  <official_title>Effectiveness of Spinal Cord Stimulation (SCS) for the Management of Freezing of Gait (FOG) and Locomotion in Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nora Vanegas-Arroyave</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      Parkinson Disease (PD) patients experience a variety of motor issues such as walking
      difficulties, loss of balance, and freezing while walking, which impacts their quality of
      life. Some symptoms, like freezing of gait (FOG), do not respond to medications typically
      used to treat PD. Current surgical procedures used to alleviate PD symptoms also do not
      always improve FOG. Since many traditional therapies have failed for the treatment of FOG,
      researchers have proposed the use of newer treatments. Recent research in animal models and
      clinical human data using SCS has produced promising results, specifically showing
      improvement in FOG with the use of SCS in patients with PD.

      The purpose of this study is to evaluate the effectiveness of spinal cord stimulation (SCS)
      for the management of freezing of gait (FOG) that does not respond to conventional treatments
      in subjects with Parkinson's disease (PD). The investigators hypothesize that SCS
      significantly decreases FOG episodes in patients with PD.

      Aim 1: To assess the effectiveness of thoracic SCS for FOG in PD patients.

      Aim 2: To evaluate the effects of SCS in locomotion, appendicular motor manifestations, and
      frequency of adverse events in PD patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Freezing of gait (FOG) is a devastating motor phenomenon which may occur in patients with
      Parkinson's Disease (PD) and other neurodegenerative disorders. It is characterized by
      episodes during which patients cannot generate effective forward stepping movements in the
      absence of motor deficits.

      FOG leads to reduced mobility, loss of independence, social embarrassment, and caregiver
      stress. While most motor features of PD respond robustly to dopaminergic agents and deep
      brain stimulation (DBS), there are currently no effective treatments for FOG.

      Indirect evidence from case reports of PD patients undergoing spinal cord stimulation (SCS)
      for neuropathic pain, has consistently described a positive effect of SCS on FOG. In
      addition, two recent reports demonstrated that thoracic SCS improved locomotion and FOG in
      patients with advanced PD. The promising role of SCS for the treatment of FOG in PD has
      encouraged us to assemble a multi-disciplinary team for the systematic investigation of the
      motor effects of SCS on FOG, locomotion and other parkinsonian features.

      The current study integrates minimally invasive SCS and the use of robotic technology to
      determine objective gait parameters. The investigators propose a pilot study for the
      implantation of SCS to the spinal cord on PD patients with treatment-refractory FOG,
      including a longitudinal assessment of motor outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2018</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>A total of 10 patients with a diagnosis of Parkinson's disease and treatment refractory freezing of gait will be recruited in this study.</intervention_model_description>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in New Freezing of Gait Questionnaire (NFOG-Q) score</measure>
    <time_frame>Baseline (pre-surgery), 3-month post-surgery, 6-month post-surgery, 12-month post-surgery</time_frame>
    <description>The New Freezing of Gait Questionnaire (NFOG-Q) is a clinician-administered tool that aims to assess both the clinical aspects of FOG as well as its subsequent impairments on quality of life. The task ratings and scales are calculated into a summed NFOG-Q score.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Timed Up and Go (TUG) score</measure>
    <time_frame>Baseline (pre-surgery), 3-month post-surgery, 6-month post-surgery, 12-month post-surgery</time_frame>
    <description>The Timed Up and Go (TUG) test assesses a person's mobility on both static and dynamic balance. The test calculates the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down to make conclusions on the person's mobility.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in 20-meter walk time (in seconds)</measure>
    <time_frame>Baseline (pre-surgery), 3-month post-surgery, 6-month post-surgery, 12-month post-surgery</time_frame>
    <description>This is a test of physical function and gait speed, which records the duration (in seconds) of a 20-meter walk at a normal self-selected pace.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in SoleSound System gait measures score</measure>
    <time_frame>Baseline (pre-surgery), 3-month post-surgery, 6-month post-surgery, 12-month post-surgery</time_frame>
    <description>The SoleSound 2.0 Footwear System is an instrumented footwear system assessment tool for quantification of spatial and temporal gait parameters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in MDS-UPDRS score</measure>
    <time_frame>Baseline (pre-surgery), 3-month post-surgery, 6-month post-surgery, 12-month post-surgery</time_frame>
    <description>The Movement Disorder Society (MDS) published a revision of the unified Parkinson's disease rating scale, known as the MDS-UPDRS. The Part III: Motor Examination portion of the scale assesses the motor signs of PD and is completed by the examiner.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Spinal Cord Stimulation (SCS)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The subjects will complete pre-operative visits, spinal cord stimulator placement (device implantation - SCS) and postoperative follow-up visits on an outpatient basis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spinal Cord Stimulator (SCS)</intervention_name>
    <description>The SCS implantation technique consists of inserting epidural leads-containing multiple stimulating electrodes (4-16). Electrodes will be implanted percutaneously into the epidural space.
The implantable pulse generator (IPG) is a neurostimulation system designed to deliver low-intensity electrical impulses. The system is intended to be used with leads and extensions that are compatible with the system. This neurostimulation system is indicated (FDA approved) as an aid in the management of chronic, intractable pain of the trunk and/or limbs. The intended use in this study is considered experimental.</description>
    <arm_group_label>Spinal Cord Stimulation (SCS)</arm_group_label>
    <other_name>Proclaimâ„¢ Implantable Pulse Generator with leads</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females between older than 18 years of age.

          -  Able to provide informed consent

          -  Diagnosed with idiopathic PD (meeting at least two of the three United Kingdom (UK)
             Brain Bank criteria for PD, specifically bradykinesia plus resting tremor or rigidity)
             whose major complaints is levodopa refractory FOG. Levodopa refractoriness will be
             defined as lack of subjective improvement on FOG episodes as reported by the patient.

          -  Documented dopaminergic response

          -  Optimized PD treatment including dopaminergic medications, and/or deep brain
             stimulation (DBS) therapy

          -  Presence of at least two self-reported levodopa refractory episodes of FOG per day,
             not limited to start hesitation

          -  At least one witnessed freezing event during the screening visit in the 'on'
             medication state (defined as 45 minutes after a regular dose of Levodopa for the
             subject being studied)

        Exclusion Criteria:

          -  Presence of any signs or symptoms suggestive of atypical or secondary parkinsonian
             syndromes, such as multiple systems atrophy (MSA), progressive supranuclear palsy
             (PSP), corticobasal ganglionic degeneration, vascular or postencephalitic
             parkinsonism:

               -  Early severe autonomic (within the first two years of symptom onset)

               -  Downward vertical supranuclear gaze palsy

               -  Early bulbar dysfunction (within the first two years of symptom onset)

               -  Unequivocal cerebellar abnormalities and/or cortical sensory loss

               -  Evidence of an alternative condition known to produce parkinsonism and plausibly
                  connected to patient's symptoms

          -  Presence of any co-morbid psychiatric illness(es) that would interfere with the
             completion of the study or pose risk to the patient.

          -  Presence of an active infection, uncontrolled diabetes mellitus, immunosuppression or
             other medical contraindications to undergoing SCS implantation

          -  Patients who are currently taking anticoagulants which would preclude the safe
             implantation of the device.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nora Vanegas-Arroyave, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Darya Tomishon</last_name>
    <phone>212-305-5779</phone>
    <email>dvt2101@cumc.columbia.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Darya Tomishon</last_name>
      <email>dvt2101@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Nora Vanegas-Arroyave, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Giladi N, Kao R, Fahn S. Freezing phenomenon in patients with parkinsonian syndromes. Mov Disord. 1997 May;12(3):302-5.</citation>
    <PMID>9159723</PMID>
  </reference>
  <reference>
    <citation>Schoneburg B, Mancini M, Horak F, Nutt JG. Framework for understanding balance dysfunction in Parkinson's disease. Mov Disord. 2013 Sep 15;28(11):1474-82. doi: 10.1002/mds.25613. Epub 2013 Aug 7. Review.</citation>
    <PMID>23925954</PMID>
  </reference>
  <reference>
    <citation>Giladi N, Kao R, Fahn S. Freezing Phenomenon , the Fifth Cardinal Sign of Parkinsonism Freezing Phenomenon in Patients with Parkinsonian Syndromes. 2016;(January). doi:10.1007/978-1-4615-5337-3.</citation>
  </reference>
  <reference>
    <citation>Espay AJ, Fasano A, van Nuenen BF, Payne MM, Snijders AH, Bloem BR. &quot;On&quot; state freezing of gait in Parkinson disease: a paradoxical levodopa-induced complication. Neurology. 2012 Feb 14;78(7):454-7. doi: 10.1212/WNL.0b013e3182477ec0. Epub 2012 Jan 18.</citation>
    <PMID>22262741</PMID>
  </reference>
  <reference>
    <citation>Fasano A, Lozano AM. Deep brain stimulation for movement disorders: 2015 and beyond. Curr Opin Neurol. 2015 Aug;28(4):423-36. doi: 10.1097/WCO.0000000000000226. Review.</citation>
    <PMID>26110808</PMID>
  </reference>
  <reference>
    <citation>FÃ©nelon G, Goujon C, Gurruchaga JM, Cesaro P, Jarraya B, Palfi S, Lefaucheur JP. Spinal cord stimulation for chronic pain improved motor function in a patient with Parkinson's disease. Parkinsonism Relat Disord. 2012 Feb;18(2):213-4. doi: 10.1016/j.parkreldis.2011.07.015. Epub 2011 Aug 23.</citation>
    <PMID>21865071</PMID>
  </reference>
  <reference>
    <citation>Soltani F, Lalkhen A. Improvement of Parkinsonian Symptoms With Spinal Cord Stimulation: Consequence or Coincidence? J Neurol Neurosurg Psychiatry. 2013;84(11):e2.74-e2. doi:10.1136/jnnp-2013-306573.165.</citation>
  </reference>
  <reference>
    <citation>Hassan S, Amer S, Alwaki A, Elborno A. A patient with Parkinson's disease benefits from spinal cord stimulation. J Clin Neurosci. 2013 Aug;20(8):1155-6. doi: 10.1016/j.jocn.2012.08.018. Epub 2013 Feb 26.</citation>
    <PMID>23453160</PMID>
  </reference>
  <reference>
    <citation>Pinto de Souza C, Hamani C, Oliveira Souza C, Lopez Contreras WO, Dos Santos Ghilardi MG, Cury RG, Reis Barbosa E, Jacobsen Teixeira M, Talamoni Fonoff E. Spinal cord stimulation improves gait in patients with Parkinson's disease previously treated with deep brain stimulation. Mov Disord. 2017 Feb;32(2):278-282. doi: 10.1002/mds.26850. Epub 2016 Nov 10.</citation>
    <PMID>27862267</PMID>
  </reference>
  <reference>
    <citation>Rohani M, Kalsi-Ryan S, Lozano AM, Fasano A. Spinal cord stimulation in primary progressive freezing of gait. Mov Disord. 2017 Sep;32(9):1336-1337. doi: 10.1002/mds.27103. Epub 2017 Jul 6. Review.</citation>
    <PMID>28681922</PMID>
  </reference>
  <reference>
    <citation>Giladi N, Tal J, Azulay T, Rascol O, Brooks DJ, Melamed E, Oertel W, Poewe WH, Stocchi F, Tolosa E. Validation of the freezing of gait questionnaire in patients with Parkinson's disease. Mov Disord. 2009 Apr 15;24(5):655-61. doi: 10.1002/mds.21745.</citation>
    <PMID>19127595</PMID>
  </reference>
  <reference>
    <citation>de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006 Jun;5(6):525-35. Review.</citation>
    <PMID>16713924</PMID>
  </reference>
  <reference>
    <citation>Shulman JM, De Jager PL, Feany MB. Parkinson's disease: genetics and pathogenesis. Annu Rev Pathol. 2011;6:193-222. doi: 10.1146/annurev-pathol-011110-130242. Review.</citation>
    <PMID>21034221</PMID>
  </reference>
  <reference>
    <citation>Turner BM, Forstmann BU, Love BC, Palmeri TJ. Approaches to analysis in model-based cognitive neuroscience. J Math Psychol. 2017;76:65-79. doi:10.1016/j.jmp.2016.01.001</citation>
  </reference>
  <reference>
    <citation>Snijders AH, Takakusaki K, Debu B, Lozano AM, Krishna V, Fasano A, Aziz TZ, Papa SM, Factor SA, Hallett M. Physiology of freezing of gait. Ann Neurol. 2016 Nov;80(5):644-659. doi: 10.1002/ana.24778. Epub 2016 Oct 7. Review.</citation>
    <PMID>27649270</PMID>
  </reference>
  <reference>
    <citation>Fleury V, Pollak P, Gere J, Tommasi G, Romito L, Combescure C, Bardinet E, Chabardes S, Momjian S, Krainik A, Burkhard P, Yelnik J, Krack P. Subthalamic stimulation may inhibit the beneficial effects of levodopa on akinesia and gait. Mov Disord. 2016 Sep;31(9):1389-97. doi: 10.1002/mds.26545. Epub 2016 Feb 17. Review.</citation>
    <PMID>26887333</PMID>
  </reference>
  <reference>
    <citation>Adams C, Keep M, Martin K, McVicker J, Kumar R. Acute induction of levodopa-resistant freezing of gait upon subthalamic nucleus electrode implantation. Parkinsonism Relat Disord. 2011 Jul;17(6):488-90. doi: 10.1016/j.parkreldis.2011.02.014. Epub 2011 Mar 11.</citation>
    <PMID>21397548</PMID>
  </reference>
  <reference>
    <citation>van Nuenen BF, Esselink RA, Munneke M, Speelman JD, van Laar T, Bloem BR. Postoperative gait deterioration after bilateral subthalamic nucleus stimulation in Parkinson's disease. Mov Disord. 2008 Dec 15;23(16):2404-6. doi: 10.1002/mds.21986.</citation>
    <PMID>18951532</PMID>
  </reference>
  <reference>
    <citation>Rocchi L, Carlson-Kuhta P, Chiari L, Burchiel KJ, Hogarth P, Horak FB. Effects of deep brain stimulation in the subthalamic nucleus or globus pallidus internus on step initiation in Parkinson disease: laboratory investigation. J Neurosurg. 2012 Dec;117(6):1141-9. doi: 10.3171/2012.8.JNS112006. Epub 2012 Oct 5.</citation>
    <PMID>23039143</PMID>
  </reference>
  <reference>
    <citation>Ferraye MU, DebÃ» B, Fraix V, Goetz L, Ardouin C, Yelnik J, Henry-Lagrange C, Seigneuret E, Piallat B, Krack P, Le Bas JF, Benabid AL, ChabardÃ¨s S, Pollak P. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain. 2010 Jan;133(Pt 1):205-14. doi: 10.1093/brain/awp229. Epub 2009 Sep 22.</citation>
    <PMID>19773356</PMID>
  </reference>
  <reference>
    <citation>Thevathasan W, Cole MH, Graepel CL, Hyam JA, Jenkinson N, Brittain JS, Coyne TJ, Silburn PA, Aziz TZ, Kerr G, Brown P. A spatiotemporal analysis of gait freezing and the impact of pedunculopontine nucleus stimulation. Brain. 2012 May;135(Pt 5):1446-54. doi: 10.1093/brain/aws039. Epub 2012 Mar 6.</citation>
    <PMID>22396391</PMID>
  </reference>
  <reference>
    <citation>Zrinzo L, Zrinzo LV, Hariz M. The peripeduncular nucleus: a novel target for deep brain stimulation? Neuroreport. 2007 Aug 6;18(12):1301-2. Erratum in: Neuroreport. 2007 Oct 8;18(15):1515. Corrected and republished in: Neuroreport. 2007 Oct 8;18(15):1631-2; author reply 1632-3.</citation>
    <PMID>17632287</PMID>
  </reference>
  <reference>
    <citation>Thevathasan W, Coyne TJ, Hyam JA, Kerr G, Jenkinson N, Aziz TZ, Silburn PA. Pedunculopontine nucleus stimulation improves gait freezing in Parkinson disease. Neurosurgery. 2011 Dec;69(6):1248-53; discussion 1254. doi: 10.1227/NEU.0b013e31822b6f71.</citation>
    <PMID>21725254</PMID>
  </reference>
  <reference>
    <citation>Compton AK, Shah B, Hayek SM. Spinal cord stimulation: a review. Curr Pain Headache Rep. 2012 Feb;16(1):35-42. doi: 10.1007/s11916-011-0238-7. Review.</citation>
    <PMID>22086473</PMID>
  </reference>
  <reference>
    <citation>Fuentes R, Petersson P, Siesser WB, Caron MG, Nicolelis MA. Spinal cord stimulation restores locomotion in animal models of Parkinson's disease. Science. 2009 Mar 20;323(5921):1578-82. doi: 10.1126/science.1164901.</citation>
    <PMID>19299613</PMID>
  </reference>
  <reference>
    <citation>Shealy CN, Mortimer JT, Reswick JB. Electrical inhibition of pain by stimulation of the dorsal columns: preliminary clinical report. Anesth Analg. 1967 Jul-Aug;46(4):489-91.</citation>
    <PMID>4952225</PMID>
  </reference>
  <reference>
    <citation>Cook AW, Weinstein SP. Chronic dorsal column stimulation in multiple sclerosis. Preliminary report. N Y State J Med. 1973 Dec 15;73(24):2868-72.</citation>
    <PMID>4543587</PMID>
  </reference>
  <reference>
    <citation>Thiriez C, Gurruchaga JM, Goujon C, FÃ©nelon G, Palfi S. Spinal stimulation for movement disorders. Neurotherapeutics. 2014 Jul;11(3):543-52. Review.</citation>
    <PMID>25015323</PMID>
  </reference>
  <reference>
    <citation>Thevathasan W, Mazzone P, Jha A, Djamshidian A, Dileone M, Di Lazzaro V, Brown P. Spinal cord stimulation failed to relieve akinesia or restore locomotion in Parkinson disease. Neurology. 2010 Apr 20;74(16):1325-7. doi: 10.1212/WNL.0b013e3181d9ed58.</citation>
    <PMID>20404313</PMID>
  </reference>
  <reference>
    <citation>Santana MB, Halje P, SimplÃ­cio H, Richter U, Freire MAM, Petersson P, Fuentes R, Nicolelis MAL. Spinal cord stimulation alleviates motor deficits in a primate model of Parkinson disease. Neuron. 2014 Nov 19;84(4):716-722. doi: 10.1016/j.neuron.2014.08.061. Epub 2014 Oct 30.</citation>
    <PMID>25447740</PMID>
  </reference>
  <reference>
    <citation>Isao TA and. The 70th Annual Meeting Special Topics â€” Part I : Validation and Prospects for Neuromodulation Spinal Cord Stimulation for the Treatment of Abnormal Posture and Gait Disorder in Patients With Parkinson Ã¢â‚¬TM s Disease. Neurol Med</citation>
  </reference>
  <reference>
    <citation>Kiriakopoulos ET, Tasker RR, Nicosia S, Wood ML, Mikulis DJ. Functional magnetic resonance imaging: a potential tool for the evaluation of spinal cord stimulation: technical case report. Neurosurgery. 1997 Aug;41(2):501-4.</citation>
    <PMID>9257323</PMID>
  </reference>
  <reference>
    <citation>Holsheimer J. Which Neuronal Elements are Activated Directly by Spinal Cord Stimulation. Neuromodulation. 2002 Jan;5(1):25-31. doi: 10.1046/j.1525-1403.2002._2005.x.</citation>
    <PMID>22151778</PMID>
  </reference>
  <reference>
    <citation>Weise D, Winkler D, Meixensberger J, Classen J. Effects of spinal cord stimulation in a patient with Parkinson's disease and chronic back pain. J Neurol. 2010;257:S217.</citation>
  </reference>
  <reference>
    <citation>Yadav AP, Nicolelis MAL. Electrical stimulation of the dorsal columns of the spinal cord for Parkinson's disease. Mov Disord. 2017 Jun;32(6):820-832. doi: 10.1002/mds.27033. Epub 2017 May 12. Review.</citation>
    <PMID>28497877</PMID>
  </reference>
  <reference>
    <citation>Gazelka HM, Freeman ED, Hooten WM, Eldrige JS, Hoelzer BC, Mauck WD, Moeschler SM, Pingree MJ, Rho RH, Lamer TJ. Incidence of clinically significant percutaneous spinal cord stimulator lead migration. Neuromodulation. 2015 Feb;18(2):123-5; discussion 125. doi: 10.1111/ner.12184. Epub 2014 May 5.</citation>
    <PMID>24796230</PMID>
  </reference>
  <reference>
    <citation>Hoelzer BC, Bendel MA, Deer TR, Eldrige JS, Walega DR, Wang Z, Costandi S, Azer G, Qu W, Falowski SM, Neuman SA, Moeschler SM, Wassef C, Kim C, Niazi T, Saifullah T, Yee B, Kim C, Oryhan CL, Rosenow JM, Warren DT, Lerman I, Mora R, Hayek SM, Hanes M, Simopoulos T, Sharma S, Gilligan C, Grace W, Ade T, Mekhail NA, Hunter JP, Choi D, Choi DY. Spinal Cord Stimulator Implant Infection Rates and Risk Factors: A Multicenter Retrospective Study. Neuromodulation. 2017 Aug;20(6):558-562. doi: 10.1111/ner.12609. Epub 2017 May 11.</citation>
    <PMID>28493599</PMID>
  </reference>
  <reference>
    <citation>Mekhail NA, Mathews M, Nageeb F, Guirguis M, Mekhail MN, Cheng J. Retrospective review of 707 cases of spinal cord stimulation: indications and complications. Pain Pract. 2011 Mar-Apr;11(2):148-53. doi: 10.1111/j.1533-2500.2010.00407.x. Epub 2010 Sep 8.</citation>
    <PMID>21371254</PMID>
  </reference>
  <reference>
    <citation>Engle MP, Vinh BP, Harun N, Koyyalagunta D. Infectious complications related to intrathecal drug delivery system and spinal cord stimulator system implantations at a comprehensive cancer pain center. Pain Physician. 2013 May-Jun;16(3):251-7.</citation>
    <PMID>23703411</PMID>
  </reference>
  <reference>
    <citation>Turner JA, Loeser JD, Deyo RA, Sanders SB. Spinal cord stimulation for patients with failed back surgery syndrome or complex regional pain syndrome: a systematic review of effectiveness and complications. Pain. 2004 Mar;108(1-2):137-47. Review.</citation>
    <PMID>15109517</PMID>
  </reference>
  <reference>
    <citation>Minto S, Zanotto D, Boggs EM, Rosati G, Agrawal SK. Validation of a Footwear-Based Gait Analysis System With Action-Related Feedback. IEEE Trans Neural Syst Rehabil Eng. 2016 Sep;24(9):971-980. doi: 10.1109/TNSRE.2015.2498287. Epub 2015 Nov 5.</citation>
    <PMID>26561476</PMID>
  </reference>
  <reference>
    <citation>Nieuwboer A, Rochester L, Herman T, Vandenberghe W, Emil GE, Thomaes T, Giladi N. Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson's disease and their carers. Gait Posture. 2009 Nov;30(4):459-63. doi: 10.1016/j.gaitpost.2009.07.108. Epub 2009 Aug 5.</citation>
    <PMID>19660949</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2018</study_first_submitted>
  <study_first_submitted_qc>May 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 16, 2018</study_first_posted>
  <last_update_submitted>May 4, 2018</last_update_submitted>
  <last_update_submitted_qc>May 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Nora Vanegas-Arroyave</investigator_full_name>
    <investigator_title>Assistant Professor of Neurology</investigator_title>
  </responsible_party>
  <keyword>Freezing of Gait</keyword>
  <keyword>Locomotion</keyword>
  <keyword>Spinal cord stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

